BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28735411)

  • 1. Risk factors associated with postoperative recurrence and repeat surgery in Japanese patients with Crohn's disease.
    Kusaka J; Shiga H; Kuroha M; Kimura T; Kakuta Y; Endo K; Kinouchi Y; Shimosegawa T
    Int J Colorectal Dis; 2017 Oct; 32(10):1407-1413. PubMed ID: 28735411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection.
    Li Y; Stocchi L; Rui Y; Remzi FH; Shen B
    Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.
    Collins M; Sarter H; Gower-Rousseau C; Koriche D; Libier L; Nachury M; Cortot A; Zerbib P; Blanc P; Desreumaux P; Colombel JF; Peyrin-Biroulet L; Pineton de Chambrun G
    J Crohns Colitis; 2017 Mar; 11(3):281-288. PubMed ID: 27578800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
    Yamada A; Komaki Y; Patel N; Komaki F; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
    Inflamm Bowel Dis; 2018 Feb; 24(3):502-509. PubMed ID: 29462385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Kjeldsen J; Nielsen J; Larsen MD; Qvist N; Nørgård BM
    Inflamm Bowel Dis; 2016 Mar; 22(3):599-606. PubMed ID: 26650149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy.
    Amiot A; Gornet JM; Baudry C; Munoz-Bongrand N; Auger M; Simon M; Allez M; Cattan P; Sarfati E; Lémann M
    Dig Liver Dis; 2011 Sep; 43(9):698-702. PubMed ID: 21474398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiopurines are associated with a reduction in surgical re-resections in patients with Crohn's disease: a long-term follow-up study in a regional and academic cohort.
    van Loo ES; Vosseberg NW; van der Heide F; Pierie JP; van der Linde K; Ploeg RJ; Dijkstra G; Nieuwenhuijs VB
    Inflamm Bowel Dis; 2013 Dec; 19(13):2801-8. PubMed ID: 24189041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD8 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease.
    Germain A; Guéant RM; Chamaillard M; Bresler L; Guéant JL; Peyrin-Biroulet L
    Dig Liver Dis; 2015 Nov; 47(11):938-42. PubMed ID: 26283210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Fumery M; Seksik P; Auzolle C; Munoz-Bongrand N; Gornet JM; Boschetti G; Cotte E; Buisson A; Dubois A; Pariente B; Zerbib P; Chafai N; Stefanescu C; Panis Y; Marteau P; Pautrat K; Sabbagh C; Filippi J; Chevrier M; Houze P; Jouven X; Treton X; Allez M;
    Am J Gastroenterol; 2017 Feb; 112(2):337-345. PubMed ID: 27958285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for Crohn's disease and anti-TNF agents: the changing scenario.
    Sorrentino D; Fogel S; Van den Bogaerde J
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):689-700. PubMed ID: 24161133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major Abdominal and Perianal Surgery in Crohn's Disease: Long-term Follow-up of Australian Patients With Crohn's Disease.
    Toh JWT; Wang N; Young CJ; Rickard MJFX; Keshava A; Stewart P; Kariyawasam V; Leong R;
    Dis Colon Rectum; 2018 Jan; 61(1):67-76. PubMed ID: 29215479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Kotze PG; Saab MP; Saab B; da Silva Kotze LM; Olandoski M; Pinheiro LV; Martinez CA; Ayrizono ML; Magro DO; Coy CS
    Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Larsen MD; Qvist N; Nielsen J; Kjeldsen J; Nielsen RG; Nørgård BM
    J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's disease.
    Boucher AL; Pereira B; Decousus S; Goutte M; Goutorbe F; Dubois A; Gagniere J; Borderon C; Joubert J; Pezet D; Dapoigny M; Déchelotte PJ; Bommelaer G; Buisson A
    World J Gastroenterol; 2016 Jun; 22(21):5068-78. PubMed ID: 27275099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immune therapy on surgical site infection following Crohn's Disease resection.
    Serradori T; Germain A; Scherrer ML; Ayav C; Perez M; Romain B; Palot JP; Rohr S; Peyrin-Biroulet L; Bresler L
    Br J Surg; 2013 Jul; 100(8):1089-93. PubMed ID: 23649458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
    Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
    Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.
    Yu CS; Jung SW; Lee JL; Lim SB; Park IJ; Yoon YS; Kim CW; Yang SK; Ye BD; Park SH; Han M; Kim JC
    Inflamm Bowel Dis; 2019 Aug; 25(9):1559-1568. PubMed ID: 30753560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn's disease.
    Yang KM; Yu CS; Lee JL; Kim CW; Yoon YS; Park IJ; Lim SB; Park SH; Ye BD; Yang SK; Kim JC
    World J Gastroenterol; 2017 Oct; 23(38):7016-7024. PubMed ID: 29097874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of Crohn's disease: indications, results and predictive factors of recurrence and morbidity.
    Hefaiedh R; Sabbeh M; Miloudi N; Ennaifer R; Romdhane H; Belhadj N; Gharbi L; Khalfallah T
    Tunis Med; 2015 Jun; 93(6):356-60. PubMed ID: 26644097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.